Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a
Rink-Jan Lohman,
Johan K. Hamidon,
Robert C. Reid,
Jessica A. Rowley,
Mei-Kwan Yau,
Maria A. Halili,
Daniel S. Nielsen,
Junxian Lim,
Kai-Chen Wu,
Zhixuan Loh,
Anh Do,
Jacky Y. Suen,
Abishek Iyer () and
David P. Fairlie ()
Additional contact information
Rink-Jan Lohman: The University of Queensland
Johan K. Hamidon: The University of Queensland
Robert C. Reid: The University of Queensland
Jessica A. Rowley: The University of Queensland
Mei-Kwan Yau: The University of Queensland
Maria A. Halili: The University of Queensland
Daniel S. Nielsen: The University of Queensland
Junxian Lim: The University of Queensland
Kai-Chen Wu: The University of Queensland
Zhixuan Loh: The University of Queensland
Anh Do: The University of Queensland
Jacky Y. Suen: The University of Queensland
Abishek Iyer: The University of Queensland
David P. Fairlie: The University of Queensland
Nature Communications, 2017, vol. 8, issue 1, 1-15
Abstract:
Abstract Complement C3a is an important protein in innate and adaptive immunity, but its specific roles in vivo remain uncertain because C3a degrades rapidly to form the C3a-desArg protein, which does not bind to the C3a receptor and is indistinguishable from C3a using antibodies. Here we develop the most potent, stable and highly selective small molecule modulators of C3a receptor, using a heterocyclic hinge to switch between agonist and antagonist ligand conformations. This enables characterization of C3 areceptor-selective pro- vs. anti-inflammatory actions in human mast cells and macrophages, and in rats. A C3a receptor-selective agonist induces acute rat paw inflammation by first degranulating mast cells before activating macrophages and neutrophils. An orally administered C3a receptor-selective antagonist inhibits mast cell degranulation, thereby blocking recruitment and activation of macrophages and neutrophils, expression of inflammatory mediators and inflammation in a rat paw edema model. These novel tools reveal the mechanism of C3a-induced inflammation and provide new insights to complement-based medicines.
Date: 2017
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-017-00414-w Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00414-w
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-017-00414-w
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().